Mar 31 2010

Home >> Clinical Trials News Archive >> 2010 >> Mar 31 2010

As a result of new regulatory responsibilities and evolving drug development activity in certain therapeutic areas, the FDA announced realignment within its Center for Drug Evaluation and Research’s (CDER) Office of New Drugs (OND), effective March 15, 2010.

Tel Aviv University is hosting a course on Medical Patents and IP, starting on April 11.

Israeli Government expands biotech funds: The fund that raises the most money wins a special $8 million government incentive funding. Four funds have met the threshold conditions of the government biotechnology fund tender. One of the funds is US equity fund OrbiMed Advisors LLC. Another fund is Medica Venture Partner. The names of the other two funds - one Israeli and the other foreign - have not been disclosed.